Speaking of semaglutide…
Published January 20, 2023
Semaglutide seems to be everywhere. News stories in The Wall Street Journal. Vanity Fair. The New York Times.
APC News
Are the compounding gods listening?
Published January 20, 2023
With release of the revised USP <797>, the compounding gods have spoken. But like Job in the Bible, we’ve got questions.
2023 APC committee leaders named
Published January 20, 2023
We welcome and congratulate these 2023 leaders of APC’s standing committees...
Assess yourself: Is your expertise up-to-date?
Published January 20, 2023
Are you up-to-speed on recent regulatory and practice protocol changes? Take a moment to assess yourself—and to see how you measure up with your peers…
Associations write FDA about suspension shortages
Published January 13, 2023
APHA, NCPA, and APC sent a joint letter to FDA this week, urging the agency to take action on suspension shortages.
Compounding directives included in FDA appropriation
Published January 13, 2023
The report that accompanies the FDA appropriation bill recently signed by President Biden includes several compounding directives for the agency.
APC Member: “OutcomeMD delivers PROs!”
Published January 13, 2023
APC member TW Taylor with Williamsburg Drug in Williamsburg, VA, has been using Outcome MD for nearly nine months, and he reports that, so far, the platform has been an excellent resource for his compounding pharmacy.
Premiering: Short advocacy update vids from APC
Published January 13, 2023
This week we debut “What We’re Working on Right Now,” the first in what will be an ongoing series of short videos (under 4 minutes!) designed to keep our members in the know on APC’s advocacy activities.
Now open: Owner Summit registration
Published January 6, 2023
APC’S Owner Summit 2023 is the year's premier in-person learning, planning, and idea-sharing event for compounding pharmacy owners and managers.
Share our DTE comment letter with your BOPs
Published January 6, 2023
APC recently submitted a comment letter on DTE to the FDA docket outlining our concerns with the recent reclassification of DTE.
“Best practices” conference is Feb 9-10
Published January 6, 2023
EduCon is the conference for keeping your team members current and compliant, and it’s coming up February 9-10, 2023. Best of all, you can earn up to 12 CE hours.
APC appeals USP <797> provisions
Published January 6, 2023
APC has notified USP that it will appeal certain provisions of the revised USP Chapter <797> and has requested 30 days to file the substance of that appeal.
A HUGE milestone: 100 PFMs
Published January 6, 2023
We launched our new "company" membership category in March 2022. As a result, we've grown from about 900 individual members last March to nearly 4,000 total members today—and we're still growing.
We salute our 2022 major investors
Published January 6, 2023
We’re deeply grateful to all who made investments in APC in 2022
Bylaws changes affect APC officer election, titles
Published December 21, 2022
APC members recently approved bylaws amendments to eliminate the office of president and change the way Alliance officers are elected.
APC submits comments to FDA on DTE
Published December 21, 2022
APC recently submitted a comment letter to FDA following the agency's communications to NABP stating that Thyroid USP was a biologic and therefore ineligible for compounding.
Welcome newest PFMs
Published December 21, 2022
We’re pleased to welcome our newest PFM members to the fold, bringing the total to 95 pharmacies and facilities that have joined APC as PFMs.
Leaders talk adverse events reporting with FDA
Published December 16, 2022
In a listening session this week with FDA officials, APC leaders outlined a draft of an adverse events reporting framework for 503As that could be incorporated into legislation in the next Congress.
Eight states get PCF grants
Published December 16, 2022
The Pharmacy Compounding Foundation is awarding $2,000 compounding continuing education grants to eight state pharmacy associations for 2023.
PFMs now sport snazzy logo on locator
Published December 16, 2022
We're at 92 Pharmacy/Facility Members and still growing!
APC briefs BOPs on GFI 256, DTE
Published December 9, 2022
This week, APC sent state boards of pharmacy two briefing memos to provide the boards of pharmacy with background, context, and guidance.
You’ve only got 27 more days…
Published December 9, 2022
EduCon is the conference for keeping your team members current and compliant, and it’s coming up February 9-10, 2023.
Dear Express Scripts…
Published December 9, 2022
APC joined five other pharmacy trade associations on a letter this week to Express Scripts and Cigna...
APC sends comments to Maine BOP
Published December 9, 2022
On November 30, APC submitted a comment letter to the Maine Board of Pharmacy regarding a proposed rule about veterinary compounding.
APC Corporate Patron Briefing set for December 15
Published December 6, 2022
APC Corporate Patrons and other vendors associated with our organization are invited to attend a briefing on Thursday, December 15th at 11:00am ET.
EduCon programming offers a buffet of learning options
Published December 2, 2022
APC's annual virtual conference focuses on compounding's best practices for keeping you and your team compliant and efficient.
On amoxicillin compounding, APC urges—and FDA acts
Published December 2, 2022
At APC’s urging, FDA has released a final guidance document stipulating minimum steps pharmacies that compound beta lactam oral antibiotic suspension products must take...
Want to be influential at APC? Sign up for a 2023 committee seat
Published December 2, 2022
2023 is coming, and with it, new opportunities for you to serve and advance your profession. One of those opportunities is for you to lend your expertise as a member of a 2023 APC volunteer committee.
We urged, FDA acted
Published November 19, 2022
Agency issues guidance on beta lactam compounding in shortage
Amoxicillin shortage: Can compounders help?
Published November 18, 2022
The start of cold and flu season has led to an immense spike in respiratory illness and also a shortage of amoxicillin oral suspension.
